For almost 15 years, we've known that narrative pathology reports occasionally lack important elements critical to the management of cancer patients. 1, 2 And for about as long, we've known that a synoptic checklist style of report increases the likelihood that all elements will be reported, results in a report that is more quickly understood by busy clinicians, and more accurately communicates findings to cancer registries. 3 Yet the narrative style persists. To understand why, we need to analyze cancer reporting as a system in which the most important factors are workflow, audience requirements, and incentives.
An ideal synoptic reporting system would seem simple to the user but have complex capabilities. ❚Table 1❚ summarizes some of the most important functional requirements of such a system. Not only does there have to be a reference service that defines what is to be communicated but also workflow must be optimized for pathologists and transcriptionists, installation must be easy, costs must be low, reporting must be highly customizable, and interfaces with downstream systems must conform to standards for communication methods and content. These requirements are interdependent, as the requirements of our downstream customers inform pathology reporting and the reference services.
Judged against this framework, the current state is far from ideal. The Association of Directors of Anatomic and Surgical Pathology (ADASP) and the College of American Pathologists (CAP) each provide a reference set of synoptic reporting checklists but in a form that is best suited for completion by pen and is not readily transmitted to tumor registries or other customers. 4, 5 They are clumsy to use with most anatomic pathology laboratory information systems (AP-LISs), and their completion is inefficient. CAP, through its Systematized Nomenclature of Medicine Clinical Terminology (SNOMED CT), also provides a set of universal codes or identifiers for each checklist item and value, but use of these codes incurs licensing costs and possible restrictions on future use of the coded data. The CAP checklists were developed as a service at a time when use was voluntary and it did not matter much that they included a few items of dubious or controversial value. Now that the American College of Surgeons (ACS) Commission on Cancer requires that cancer resection reports include all scientifically validated items in the CAP checklists, inclusion of questionable items as required in the checklists can result in pathologists doing meaningless work to maintain institutional accreditation as a cancer center. There are also few incentives to adopt the CAP checklists other than altruistic notions of report quality and perceived marginal benefit of first-pass complete reporting.
In this issue of the Journal, Qu et al 6 describe a Webbased system to increase the usability of the content of the CAP templates. By converting the CAP checklists to a dynamic format based on the Microsoft (Microsoft, Redmond, WA) ASP.NET (Active Server Page), they delivered a system that greatly increases human usability, is compatible with most AP-LISs, and meets many of the other functional requirements of an ideal system. Their Web service eliminates some of the worst usability problems with the CAP and ADASP checklists. This innovative approach could be the core of an Internet-based service for generating synoptic cancer reports.
Yet it is only a partial solution because this early version lacks some features needed for transmitting results to nonhuman customers (universal identifiers [IDs] and data persistence) and lacks some of the flexibility needed for use by multiple institutions.
Why universal IDs? Certainly no human involved in patient care needs or wants to deal with cryptic coded values that are interpretable only with the help of large lookup tables. In fact, these codes should be masked from sight whenever possible to avoid inhibiting communication with human beings. It is because accurate communication with downstream tumor registries, specimen repositories, and electronic medical records is a fundamental functional requirement of the cancer reporting system that universal IDs must be used. The process of translating a pathologist's diagnosis to a narrative written description has a nonzero error rate, as does the process of a tumor registrar (or the registrar's software) translating the written description back to one of a discrete list of choices allowed by the tumor registry. It is much better to capture the universal ID at the time the pathologist makes the diagnosis. The key is to make the pathologist's workflow to choose specific diagnoses (and associated universal IDs) easier than to create narrative reports.
Which set of universal IDs should be used? SNOMED CT is a viable choice, and its codes have already been associated with the CAP checklists. Licensing costs and possible limitations on future use are disincentives. The Cancer Biomedical Informatics Grid (caBIG) initiative of the National Cancer Institute has developed a public use terminology (Enterprise Vocabulary Service) with concepts analogous in coverage to those of SNOMED CT. To date, the caBIG identifiers have only been associated with a few of the CAP checklists. 7 Neither is necessarily the perfect solution because the ultimate downstream cancer registries (like Surveillance, Epidemiology, and End Results) use the International Classification of Diseases (ICD) for Oncology (third edition), ICD (tenth revision), and their own internal codes for extent of disease. Because SNOMED CT, caBIG, and other codes can all be cross-walked to the codes used by the downstream registries, it is probably more important to specify the coding system used than to adopt a single system universally.
Data persistence is a 2-edged sword. If you keep data, you have to protect it-not keeping data is one of the cheapest approaches to Health Information Portability and Accountability Act compliance, and this it the approach taken by Qu et al. 6 On the other hand, retention of the synoptic report data as discrete data elements opens many functional possibilities: drafts of synoptic reports can be saved for later completion; synoptic data can be formatted differently for different interfaces or purposes; reports can be corrected by changing only specific values rather than redoing the whole template; synoptic data can be provided to different systems asynchronously or even in response to queries. The AP-LIS (or synoptic report-generating system) can be the single source of truth-the ultimate reference for other systems-if the synoptic data are retained. The most critical thing, though, is to guarantee that synoptic data published in pathology reports are exactly the same as in the synoptic database.
Synoptic report templates will evolve over time, and there must be automated methods to update local sites that have adopted versions of the reference templates. Universal IDs linked to each template item might be dual-purposed to aid with updates; if not, some alternative numbering system for the reference template items will have to be developed and used for this purpose.
Traditional AP-LIS vendors have been slow to deliver synoptic reporting functionality, although several now offer this capability. Independent companies have also stepped into the breach to offer solutions. Are there alternatives to shrink-wrapped products that can be implemented in a more timely manner? The approach of Qu et al 6 points in a promising direction. An enhanced version could store site-specific template and formatting information so that users accessing the same system from multiple sites could each use their own customized reports. With proper design and security, synoptic results could be stored server-side and even interfaced from there to tumor registries and similar systems. Local templates could be adjusted quickly if and when CAP checklists change. In fact, almost all of the requirements listed in Table 1 could be met by a Web application. The most difficult problem is guaranteeing that the data in the server-side synoptic repository are identical to data in the pathology reports; some process would have to be developed to ensure that the content of revised reports is correctly reflected in the synoptic data repository. CAP is obviously in an excellent position to provide or coordinate such a service, but Qu et al 6 have shown that talented programmers from anywhere can deliver a viable solution.
One of the main purposes of synoptic cancer reports is to summarize in compact form multiple observations of possible prognostic value. In their current form, though, the CAP checklists do not give any indication of the relative strength of prognostic indicators and some factors are listed as "required" that have dubious prognostic value at best. A problem this causes is that only sophisticated readers have the background to understand the relative prognostic value of different observations; other readers simply see a laundry list of factors and may be inclined to weight them equally. One possible solution is to annotate the synoptic reports with indicators of the level of proof each has achieved as a prognostic indicator. Because stage is the strongest prognostic factor in almost every organ system, stage should be included in any statistical test of value. A proposal is listed in ❚Table 2❚.
The best cancer reporting system in the world won't be used if the incentives are not right. What incentives operate in this setting? At present, the only positive incentives are the satisfaction of delivering complete cancer reports on the first pass and a sense of altruism that one is doing the right thing. ACS provides a negative incentive. Current disincentives to adopt synoptic reporting include added costs for new software, poor workflow, change in reporting style, licensing fees, and the sense that some of the CAP-required parameters are wasted effort. Well-written synoptic report software can increase the speed and accuracy of reporting, thus providing a positive incentive to adopt this style. But software is only part of the story. The quality and transparency of the checklists also need to improve. And financial incentives that ease the transition costs would likely have a salutary effect. 
